Chai Discovery has announced a $130 million Series B financing round co-led by Oak HC/FT and General Catalyst. The news follows Chai’s most recent announcement, where the company showed its latest models can now design molecules with important “developability” properties and tackle “hard-to-drug” targets that have historically been challenging for traditional techniques. The round also […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!